article_metadata: Coralie Zumelzu Marina Alexandre Christelle Le Roux Patricia Weber Alexis Guyot Annie Levy Françoise Aucouturier Sabine Mignot-Grootenboer Frédéric Caux Eve Maubec Catherine Prost-Squarcioni
article_metadata: 10.3389/fmed.2018.00268
article_metadata: Front Med (Lausanne)
article_metadata: 2018 Sep 27;5:268.
article_metadata: adverse drug reaction anti-programmed-death-1/death-ligand-1 bullous pemphigoid drug accountability study immune checkpoints inhibitors melanoma mucous membrane pemphigoid pembrolizumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/30320114/
article_metadata: Case Reports
article_metadata: PMC6170650
article_metadata: 30320114
article_metadata: Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature
article_metadata: 2018